Only 67% of high-cardiovascular-risk patients are treated with lipid-modifying therapy (LMT), of which only 7%

The reduction in HbA1c is greater in patients starting basal insulin or insulin glargine compared

Chemotherapy treatment for ovarian cancer (OC) is diverse, predominantly in later lines of treatment. There

In 2004 and 2008 studies showed that approximately 10.000-16.000 of the acute hospitalisations were related

  The prevalence of diabetes in the Netherlands increased from 1.8% in 1999 to 4.9%

In the current issue: Medication for disorders of the central nervous system, RWE for market access

Treatment after venous thromboembolism (VTE) as captured in observational healthcare data generally follows the Dutch

First results and interim advice The stock-out of Thyrax Duotab in the Netherlands forced thousands

Characterisation and cholesterol management in patients with cardiovascular events and/or type 2 diabetes in the

Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated